BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20543711)

  • 1. Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients.
    Testa A; Mallamaci F; Macrì R; Pisano A; Spoto B; Malatino LS; Stancanelli B; Tripepi G; Benedetto FA; Zoccali C
    J Hypertens; 2010 Aug; 28(8):1745-51. PubMed ID: 20543711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
    Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
    Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients.
    Losito A; Kalidas K; Santoni S; Jeffery S
    Kidney Int; 2003 Aug; 64(2):616-22. PubMed ID: 12846758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.
    Panuccio V; Cutrupi S; Pizzini P; Mallamaci F; Tripepi G; Zoccali C
    Am J Kidney Dis; 2007 Dec; 50(6):1001-8. PubMed ID: 18037100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of contractile function through neuropeptide Y receptors during development of cardiomyocyte hypertrophy.
    Allen AR; Kelso EJ; Bell D; Zhao Y; Dickson P; McDermott BJ
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1286-96. PubMed ID: 16973886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients.
    Testa A; Mallamaci F; Benedetto FA; Pisano A; Tripepi G; Malatino L; Thadhani R; Zoccali C
    J Bone Miner Res; 2010 Feb; 25(2):313-9. PubMed ID: 20422622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and cardiac neuropeptide Y and NPY receptors in a rat model of congestive heart failure.
    Callanan EY; Lee EW; Tilan JU; Winaver J; Haramati A; Mulroney SE; Zukowska Z
    Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1811-7. PubMed ID: 17804485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can angiotensin II +1675 G/A type 2 receptor gene polymorphism be a marker of left ventricular hypertrophy in patients with aortic stenosis?
    Orlowska-Baranowska E; Placha G; Baranowski R; Michalek P; Gora J; Gaciong Z; Stepinska J
    J Heart Valve Dis; 2007 Sep; 16(5):495-503. PubMed ID: 17944121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y gene polymorphism and plasma neuropeptide Y level in febrile seizure patients in Taiwan.
    Lin LC; Lin HS; Yang RC
    Kaohsiung J Med Sci; 2007 Nov; 23(11):560-5. PubMed ID: 18055304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Parlongo S; Cutrupi S; Bonanno G; Rapisarda F; Fatuzzo P; Seminara G; Cataliotti A; Malatino LS
    J Hypertens; 2003 Jul; 21(7):1355-62. PubMed ID: 12817184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients.
    Kutlay S; Dincer I; Sengül S; Nergizoglu G; Duman N; Ertürk S
    Am J Kidney Dis; 2006 Mar; 47(3):485-92. PubMed ID: 16490628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of insulin-like growth factor-1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension.
    Horio T; Kamide K; Takiuchi S; Yoshii M; Miwa Y; Matayoshi T; Yoshihara F; Nakamura S; Tokudome T; Miyata T; Kawano Y
    J Hum Hypertens; 2010 May; 24(5):320-6. PubMed ID: 19759555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
    Smilde TD; Zuurman MW; Hillege HL; van Veldhuisen DJ; van Gilst WH; van der Steege G; Voors AA; Kors JA; de Jong PE; Navis G
    Am J Hypertens; 2007 Oct; 20(10):1097-103. PubMed ID: 17903694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evolution and changing associations of left ventricular hypertrophy after starting hemodialysis.
    Takeda A; Toda T; Iwamoto H; Watanabe K; Matsui N
    Nephron Clin Pract; 2008; 110(2):c126-32. PubMed ID: 18931516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in diabetic haemodialysis patients.
    Nishimura M; Hashimoto T; Kobayashi H; Fukuda T; Okino K; Yamamoto N; Nakamura N; Yoshikawa T; Takahashi H; Ono T
    Nephrol Dial Transplant; 2004 Oct; 19(10):2532-8. PubMed ID: 15252162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
    Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
    Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy.
    Brugada R; Kelsey W; Lechin M; Zhao G; Yu QT; Zoghbi W; Quinones M; Elstein E; Omran A; Rakowski H; Wigle D; Liew CC; Sole M; Roberts R; Marian AJ
    J Investig Med; 1997 Dec; 45(9):542-51. PubMed ID: 9444881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.